Research on peptides like DSIP and Epithalon shows favorable long-term safety profiles with decades of study, particularly when used at appropriate dosages with periodic breaks. Unlike pharmaceutical sleep aids that can cause dependency and cognitive decline with extended use, these peptides work by supporting natural physiological processes. Most experts recommend using them in 8-12 week cycles with reassessment periods rather than indefinite continuous use.
PMC: Long-term peptide safety